Difficulty: Medium
Average Score: 79%
Testbank
Diagnostic testing has resulted in a diagnosis of acute myeloid leukemia (AML) in an adult patient who is otherwise healthy. The patient and the care team have collaborated and the patient will soon begin induction therapy. The nurse should prepare the patient for which of the following?
Correct answer
D
Rationale
An aggressive course of chemotherapy is the primary treatment approach for induction therapy in patients diagnosed with acute myeloid leukemia (AML).
This option is appropriate because induction therapy for AML typically involves intensive chemotherapy to achieve remission by rapidly killing leukemic cells. It aims to restore normal hematopoiesis and is essential for managing this aggressive malignancy effectively.
A: Daily treatment with targeted therapy medications would not be suitable for AML induction therapy, as this approach is not standard for initial treatment and is more relevant for specific subtypes or conditions.
B: Radiation therapy on a daily basis is not a typical component of induction therapy for AML, as chemotherapy is the mainstay treatment, and radiation is generally reserved for specific situations such as palliative care or prior to stem cell transplantation.
C: Hematopoietic stem cell transplantation is not initiated at the induction phase; it is considered after achieving remission with chemotherapy, making it an inappropriate choice for the immediate treatment plan for this patient.
This option is appropriate because induction therapy for AML typically involves intensive chemotherapy to achieve remission by rapidly killing leukemic cells. It aims to restore normal hematopoiesis and is essential for managing this aggressive malignancy effectively.
A: Daily treatment with targeted therapy medications would not be suitable for AML induction therapy, as this approach is not standard for initial treatment and is more relevant for specific subtypes or conditions.
B: Radiation therapy on a daily basis is not a typical component of induction therapy for AML, as chemotherapy is the mainstay treatment, and radiation is generally reserved for specific situations such as palliative care or prior to stem cell transplantation.
C: Hematopoietic stem cell transplantation is not initiated at the induction phase; it is considered after achieving remission with chemotherapy, making it an inappropriate choice for the immediate treatment plan for this patient.